iifl-logo

Aurobindo Pharma Ltd EGM

1,161.1
(0.14%)
Jun 6, 2025|12:00:00 AM

Aurobindo Pharma CORPORATE ACTIONS

07/06/2024calendar-icon
07/06/2025calendar-icon

No Record Found

Aurobindo Pharma: Related News

Top Stocks for Today - 27th May 2025
27 May 2025|06:36 AM

Here are some of the stocks that may see significant price movement today: Lupin, IndiGo, Nazara Tech, Aurobindo Pharma, etc.

Read More
Aurobindo Pharma Q4 Profit Slips Marginally to ₹903 Crore
26 May 2025|09:14 PM

Annual income at the company also grew by a big margin of ₹31,724 crore in FY25 from ₹29,002 crore in FY24, up 9.4% on yearly basis

Read More
Top Stocks for Today - 29th April 2025
29 Apr 2025|06:38 AM

Here are some of the stocks that may see significant price movement today: Gensol Engineering, Oberoi Realty, TVS Motor Company, etc.

Read More
Aurobindo Pharma Gets USFDA Nod for Leukemia Drug Dasatinib
23 Apr 2025|01:24 PM

Aurobindo Pharma is going to launch Dasatinib in Q1 FY26, which will be in line with its plans to enhance its oncology portfolio in the US generics market.

Read More
Aurobindo Pharma Gets 11 FDA Observations After US Plant Inspection
15 Apr 2025|12:29 PM

Following the audit, the US FDA issued a Form 483 with 11 observations at closure, which Aurobindo Pharma described as small procedural observations.

Read More
Top Stocks for Today - 15th April 2025
15 Apr 2025|06:15 AM

Here are some of the stocks that may see significant price movement today: GAIL, Zydus Lifesciences, Aurobindo Pharma, etc.

Read More
Aurobindo Pharma’s CuraTeQ completes phase I of bone drug study
11 Apr 2025|09:01 AM

As per the company, the drug functions by blocking a protein called RANKL, which is responsible for breaking down bone tissue.

Read More
Top Stocks for Today - 11th April 2025
11 Apr 2025|06:34 AM

Here are some of the stocks that may see significant price movement today: BHEL, Coromandel International, Aurobindo Pharma, etc.

Read More
Aurobindo Pharma’s Eugia gets 5 observations from USFDA
19 Feb 2025|01:39 PM

As per the company’s filing with the bourses, the inspection was concluded with five procedural observations.

Read More
Aurobindo Pharma Q3 Profit Falls 9.7% YoY, Revenue Up 8.5%
6 Feb 2025|11:06 PM

Revenue increased by 8.5% YoY to ₹7,978.5 crore.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.